Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray.

Puderbach M, Eichinger M, Haeselbarth J, Ley S, Kopp-Schneider A, Tuengerthal S, Schmaehl A, Fink C, Plathow C, Wiebel M, Demirakca S, Müller FM, Kauczor HU.

Invest Radiol. 2007 Oct;42(10):715-25.

PMID:
17984769
2.

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.

Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW.

Pediatr Pulmonol. 2007 Jul;42(7):610-23.

PMID:
17534969
3.

Dose reduction in paediatric MDCT: general principles.

Paterson A, Frush DP.

Clin Radiol. 2007 Jun;62(6):507-17. Epub 2007 Mar 23. Review.

PMID:
17467387
4.

Pseudomonas serology: confusion, controversy, and challenges.

Farrell PM, Govan JR.

Thorax. 2006 Aug;61(8):645-7. Epub 2006 Jun 12. No abstract available.

5.

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM.

J Thorac Imaging. 2006 Mar;21(1):14-21.

PMID:
16538150
6.

Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Twiss J, Stewart AW, Byrnes CA.

Thorax. 2006 May;61(5):414-8. Epub 2006 Feb 7.

7.

Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis.

Kappler M, Kraxner A, Reinhardt D, Ganster B, Griese M, Lang T.

Thorax. 2006 Aug;61(8):684-8. Epub 2006 Jan 31.

8.

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM.

J Cyst Fibros. 2006 Jan;5(1):33-41. Epub 2005 Nov 4.

9.

Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis.

Brody AS, Sucharew H, Campbell JD, Millard SP, Molina PL, Klein JS, Quan J.

Am J Respir Crit Care Med. 2005 Nov 1;172(9):1128-32. Epub 2005 Aug 11.

PMID:
16100015
10.

Computed tomography in the evaluation of cystic fibrosis lung disease.

Brody AS, Tiddens HA, Castile RG, Coxson HO, de Jong PA, Goldin J, Huda W, Long FR, McNitt-Gray M, Rock M, Robinson TE, Sagel SD; CT Scanning in Cystic Fibrosis Special Interest Group.

Am J Respir Crit Care Med. 2005 Nov 15;172(10):1246-52. Epub 2005 Aug 11.

PMID:
16100011
11.

Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.

Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT.

J Clin Microbiol. 2005 Aug;43(8):3956-62.

12.

Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic.

Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, Massie J, Armstrong DS.

Am J Respir Crit Care Med. 2005 May 1;171(9):1020-5. Epub 2005 Feb 11.

PMID:
15709051
13.

Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

Sadikot RT, Blackwell TS, Christman JW, Prince AS.

Am J Respir Crit Care Med. 2005 Jun 1;171(11):1209-23. Epub 2005 Feb 1. Review.

14.

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML.

JAMA. 2005 Feb 2;293(5):581-8.

PMID:
15687313
15.

Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia.

Valery PC, Torzillo PJ, Mulholland K, Boyce NC, Purdie DM, Chang AB.

Pediatr Infect Dis J. 2004 Oct;23(10):902-8.

PMID:
15602188
16.

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS; CDC.

MMWR Recomm Rep. 2004 Oct 15;53(RR-13):1-36. Review.

17.
18.

Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements.

de Jong PA, Ottink MD, Robben SG, Lequin MH, Hop WC, Hendriks JJ, Paré PD, Tiddens HA.

Radiology. 2004 May;231(2):434-9. Epub 2004 Apr 2.

PMID:
15064392
19.

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

Moss RB, Rodman D, Spencer LT, Aitken ML, Zeitlin PL, Waltz D, Milla C, Brody AS, Clancy JP, Ramsey B, Hamblett N, Heald AE.

Chest. 2004 Feb;125(2):509-21.

PMID:
14769732
20.

Structural airway abnormalities in infants and young children with cystic fibrosis.

Long FR, Williams RS, Castile RG.

J Pediatr. 2004 Feb;144(2):154-61.

PMID:
14760252

Supplemental Content

Support Center